Cargando…
PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelial-mesenchymal transition
Epithelial-mesenchymal transition (EMT) has an established role in the acquisition of therapeutic resistance. Programmed cell death domain 2 (PDCD2) is involved in the progression of multiple types of cancer. However, its mechanism underlying chemoresistance in liver cancer has not been elucidated....
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390009/ https://www.ncbi.nlm.nih.gov/pubmed/30664177 http://dx.doi.org/10.3892/mmr.2019.9860 |